tiprankstipranks
Trending News
More News >
Johnson & Johnson (JNJ) Is About to Report Its Q1 Earnings Tomorrow. Here Is What to Expect
PremiumMarket NewsJohnson & Johnson (JNJ) Is About to Report Its Q1 Earnings Tomorrow. Here Is What to Expect
23h ago
Johnson & Johnson (JNJ) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Johnson & Johnson (JNJ) Q1 Earnings Cheat Sheet
2d ago
Novartis Stock (NVS) Looks Healthier as it Spends $23B on Ramping Up U.S. Manufacturing
Premium
Market News
Novartis Stock (NVS) Looks Healthier as it Spends $23B on Ramping Up U.S. Manufacturing
4d ago
Johnson & Johnson’s Darzalex with Halozyme’s Enhanze granted EU approval
PremiumThe FlyJohnson & Johnson’s Darzalex with Halozyme’s Enhanze granted EU approval
6d ago
Johnson & Johnson price target raised to $164 from $163 at Morgan Stanley
Premium
The Fly
Johnson & Johnson price target raised to $164 from $163 at Morgan Stanley
6d ago
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
Premium
The Fly
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
6d ago
J&J announces EC approved extension of marketing authorization for Rybrevant
PremiumThe FlyJ&J announces EC approved extension of marketing authorization for Rybrevant
8d ago
Johnson & Johnson Faces Legal Hurdles: Stock Tumbles
Premium
Weekend Updates
Johnson & Johnson Faces Legal Hurdles: Stock Tumbles
10d ago
Johnson & Johnson: Tremfya Phase 3b APEX study achieved primary endpoint
Premium
The Fly
Johnson & Johnson: Tremfya Phase 3b APEX study achieved primary endpoint
11d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100